|
⚲
|
| Keyboard |
| Eran Nadav | |
|---|---|
| Firm | |
| Address | 3675 Market Street Suite 200 Philadelphia, PA 19104 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Carisma Therapeutics Inc | 021-316355 | Director | 52.9 M of 52.9 M |
||
| Trevi Therapeutics Inc | 021-291383 | Director | 51.9 M of 61.9 M |
||
| Collegium Pharmaceutical Inc | 021-235865 | Director | 50.0 M of 50.0 M |
||
| Novasom Inc | 021-218559 | Director | 6.0 M of 8.0 M |
||
| Ultragenyx Pharmaceutical Inc | 021-189181 | Director | 75.0 M of 75.0 M |
||
| Trevi Therapeutics Inc | 021-188569 | Director | 6.6 M of 13.1 M |
||
| Ultragenyx Pharmaceutical Inc | 021-181946 | Director | 15.1 M of 30.1 M |
||
| Ultragenyx Pharmaceutical Inc | 021-161694 | Director | 18.7 M of 48.7 M |
||